1568 related articles for article (PubMed ID: 15838185)
41. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
42. Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 1, a pharmacokinetic/pharmacodynamic comparison with paroxetine in healthy men.
Wilson S; Højer AM; Buchberg J; Areberg J; Nutt DJ
J Psychopharmacol; 2015 Oct; 29(10):1085-91. PubMed ID: 26253622
[TBL] [Abstract][Full Text] [Related]
43. Recovery after prolonged sleep deprivation: residual effects of slow-release caffeine on recovery sleep, sleepiness and cognitive functions.
Beaumont M; Batéjat D; Coste O; Doireau P; Chauffard F; Enslen M; Lagarde D; Pierard C
Neuropsychobiology; 2005; 51(1):16-27. PubMed ID: 15627809
[TBL] [Abstract][Full Text] [Related]
44. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
45. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
46. Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia.
Herrera-Arellano A; Luna-Villegas G; Cuevas-Uriostegui ML; Alvarez L; Vargas-Pineda G; Zamilpa-Alvarez A; Tortoriello J
Planta Med; 2001 Nov; 67(8):695-9. PubMed ID: 11731907
[TBL] [Abstract][Full Text] [Related]
47. Automatic sleep classification according to Rechtschaffen and Kales.
Anderer P; Gruber G; Parapatics S; Dorffner G
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3994-7. PubMed ID: 18002875
[TBL] [Abstract][Full Text] [Related]
48. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
Sharpley AL; Williamson DJ; Attenburrow ME; Pearson G; Sargent P; Cowen PJ
Psychopharmacology (Berl); 1996 Jul; 126(1):50-4. PubMed ID: 8853216
[TBL] [Abstract][Full Text] [Related]
49. Sleep improves when patients with chronic OA pain are managed with morning dosing of once a day extended-release morphine sulfate (AVINZA): findings from a pilot study.
Rosenthal M; Moore P; Groves E; Iwan T; Schlosser LG; Dziewanowska Z; Negro-Vilar A
J Opioid Manag; 2007; 3(3):145-54. PubMed ID: 18027540
[TBL] [Abstract][Full Text] [Related]
50. Exploratory polysomnographic evaluation of pregabalin on sleep disturbance in patients with epilepsy.
de Haas S; Otte A; de Weerd A; van Erp G; Cohen A; van Gerven J
J Clin Sleep Med; 2007 Aug; 3(5):473-8. PubMed ID: 17803010
[TBL] [Abstract][Full Text] [Related]
51. Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers.
Wilson SJ; Bailey JE; Alford C; Nutt DJ
J Psychopharmacol; 2000; 14(4):378-86. PubMed ID: 11198056
[TBL] [Abstract][Full Text] [Related]
52. Gabapentin improves sleep in the presence of alcohol.
Bazil CW; Battista J; Basner RC
J Clin Sleep Med; 2005 Jul; 1(3):284-7. PubMed ID: 17566190
[TBL] [Abstract][Full Text] [Related]
53. Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects.
Cohrs S; Meier A; Neumann AC; Jordan W; Rüther E; Rodenbeck A
J Clin Psychiatry; 2005 Aug; 66(8):989-96. PubMed ID: 16086613
[TBL] [Abstract][Full Text] [Related]
54. Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia.
Bettica P; Squassante L; Groeger JA; Gennery B; Winsky-Sommerer R; Dijk DJ
Neuropsychopharmacology; 2012 Apr; 37(5):1224-33. PubMed ID: 22237311
[TBL] [Abstract][Full Text] [Related]
55. Changes of sleep adaptation in hospitalized patients with depression.
Song S; Geng Z; Zhai S; Xu J; Hou G; Zhang X
Cell Biochem Biophys; 2013 Jun; 66(2):347-50. PubMed ID: 23076639
[TBL] [Abstract][Full Text] [Related]
56. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Gruber G; Mandl M; Strobl R; Gollner D; Prause W; Saletu B
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):249-60. PubMed ID: 11817501
[TBL] [Abstract][Full Text] [Related]
57. Effects of caffeine are more marked on daytime recovery sleep than on nocturnal sleep.
Carrier J; Fernandez-Bolanos M; Robillard R; Dumont M; Paquet J; Selmaoui B; Filipini D
Neuropsychopharmacology; 2007 Apr; 32(4):964-72. PubMed ID: 16936703
[TBL] [Abstract][Full Text] [Related]
58. Can an inert sleeping pill affect sleep? Effects on polysomnographic, behavioral and subjective measures.
Fratello F; Curcio G; Ferrara M; Marzano C; Couyoumdjian A; Petrillo G; Bertini M; De Gennaro L
Psychopharmacology (Berl); 2005 Oct; 181(4):761-70. PubMed ID: 15986193
[TBL] [Abstract][Full Text] [Related]
59. Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers.
Barbanoj MJ; Riba J; Clos S; Giménez S; Grasa E; Romero S
Psychopharmacology (Berl); 2008 Feb; 196(2):315-26. PubMed ID: 18030450
[TBL] [Abstract][Full Text] [Related]
60. [Contribution of zolpidem in the management of sleep disorders].
Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
